Expression of microRNAs is essential for arterial myogenic tone and pressure-induced activation of the PI3-kinase/Akt pathway

Cardiovascular Research

Volumn 101, Issue 2, 2014, Pages 288-296

  Bhattachariya, Anirban ^a   Dahan, Diana ^a   Turczyńska, Karolina M ^a   Swärd, Karl ^a   Hellstrand, Per ^a   Albinsson, Sebastian ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Angiotensin; Calcium; MicroRNA; Myogenic tone; PI 3 kinase

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CALCIUM; CALCIUM CHANNEL L TYPE; CANDESARTAN; DICER; MICRORNA; MICRORNA 26A; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TAMOXIFEN; VOLTAGE GATED CALCIUM CHANNEL;

ARTERY BLOOD FLOW; ARTERY PERFUSION; ARTERY RESISTANCE; ARTERY TONE; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM TRANSPORT; CELL DIFFERENTIATION; ENZYME ACTIVATION; GENE INACTIVATION; MESENTERIC ARTERY; MOUSE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE TONE; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN; CALCIUM; MICRORNA; MYOGENIC TONE; PI 3-KINASE;

ANIMALS; ARTERIAL PRESSURE; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELLS, CULTURED; DEAD-BOX RNA HELICASES; ENZYME ACTIVATION; GENOTYPE; MECHANOTRANSDUCTION, CELLULAR; MESENTERIC ARTERIES; MICE; MICE, KNOCKOUT; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RENIN-ANGIOTENSIN SYSTEM; RIBONUCLEASE III; TIME FACTORS; TRANSFECTION; VASOCONSTRICTION; VASODILATION;

EID: 84893099457     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt253     Document Type: Article

References (41)

1. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999;79:387-423
2. Hill MA, Meininger GA, Davis MJ, Laher I. Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends Pharmacol Sci 2009;30:363-374
3. Moreno-Dominguez A, Colinas O, El-Yazbi A,Walsh EJ, Hill MA,Walsh MP et al. Ca2+ sensitization due to myosin light chain phosphatase inhibition and cytoskeletal reorganization in the myogenic response of skeletalmuscle resistance arteries. J Physiol 2013;591: 1235-1250
4. SchubertR, Lidington D, Bolz SS. The emerging role of Ca2+ sensitivity regulation in promoting myogenic vasoconstriction. Cardiovasc Res 2008;77:8-18
5. Carnevale D, Vecchione C, Mascio G, Esposito G, Cifelli G, MartinelloKet al. PI3Kgamma inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism. Cardiovasc Res 2012;93:200-209
6. Albinsson S, Skoura A, Yu J, Dilorenzo A, Fernandez-Hernando C, Offermanns S et al. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One 2011;6:e18869
7. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol 2010;30:1118-1126
8. Turczynska KM, Sadegh MK, Hellstrand P, Sward K, Albinsson S. MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via micro-RNA (miR)-145-dependent expression of L-type calcium channels. J Biol Chem 2012; 287:19199-19206
9. Albinsson S, Sward K. Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease. Pharmacol Res 2013;75:28-36
10. Wirth A, Benyo Z, Lukasova M, Leutgeb B, Wettschureck N, Gorbey S et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for saltinduced hypertension. Nat Med 2008;14:64-68
11. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 2005;201:1367-1373
12. Retailleau K, Toutain B, Galmiche G, Fassot C, Sharif-Naeini R, Kauffenstein G et al. Selective involvement of serum response factor in pressure-induced myogenic tone in resistance arteries. Arterioscler Thromb Vasc Biol 2013;33:339-346
13. Albinsson S, Shakirova Y, Rippe A, Baumgarten M, Rosengren BI, Rippe C et al. Arterial remodeling and plasma volume expansion in caveolin-1-deficient mice. Am J Physiol Regul Integr Comp Physiol 2007;293:R1222-R1231
14. Turczynska KM, Bhattachariya A, Sall J, Goransson O, Sward K, Hellstrand P et al. Stretch-sensitive down-regulation of the miR-144/451 cluster in vascular smooth muscle and its role in AMP-activated protein kinase signaling. PLoS One 2013;8: E65135
15. Sadegh MK, Ekman M, Rippe C, Uvelius B, Sward K, Albinsson S. Deletion of dicer in smooth muscle affects voiding pattern and reduces detrusor contractility and neuroeffector transmission. PLoS One 2012;7:e35882
16. Zou H, Ratz PH, Hill MA. Role of myosin phosphorylation and [Ca2+]i in myogenic reactivity and arteriolar tone. Am J Physiol 1995;269:H1590-H1596
17. Bannister JP, Bulley S, Narayanan D, Thomas-Gatewood C, Luzny P, Pachuau J et al. Transcriptional upregulation of alpha2delta-1 elevates arterial smooth muscle cell voltagedependent Ca2+ channel surface expression and cerebrovascular constriction in genetic hypertension. Hypertension 2012;60:1006-1015
18. Vecchione C, Patrucco E, MarinoG, Barberis L, Poulet R, AretiniAet al. Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma. J Exp Med 2005;201:1217-1228
19. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579-1588
20. Huse JT, Brennan C, Hambardzumyan D,Wee B, Pena J, RouhanifardSHet al. The PTENregulating microRNA miR-26a isamplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009;23:1327-1337
21. Tumaneng K, Schlegelmilch K, Russell RC, YimlamaiD, Basnet H, MahadevanNet al.YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol 2012;14:1322-1329
22. Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F et al. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat Neurosci 2004;7:939-946
23. Catalucci D, Zhang DH, DeSantiago J, Aimond F, Barbara G, Chemin J et al. Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. J Cell Biol 2009; 184:923-933
24. Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JWet al. Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J 2003;22:6027-6034
25. Turczynska KM, Hellstrand P, Sward K, Albinsson S. Regulation of vascular smooth muscle mechanotransduction by microRNAs and L-type calcium channels. Commun Integr Biol 2013;6:e22278
26. Pinho JF, Medeiros MA, Capettini LS, Rezende BA, Campos PP, Andrade SP et al. Phosphatidylinositol 3-kinase-delta up-regulates L-type Ca2+ currents and increases vascular contractility in a mouse model of type 1 diabetes. Br J Pharmacol 2010;161: 1458-1471
27. Le Blanc C, Mironneau C, Barbot C, Henaff M, Bondeva T,Wetzker R et al. Regulation of vascular L-type Ca2+ channels by phosphatidylinositol 3,4,5-trisphosphate. Circ Res 2004;95:300-307
28. Zhou RH, Lee TS, Tsou TC, Rannou F, Li YS, Chien S et al. Stent implantation activates Akt in the vessel wall: Role of mechanical stretch in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003;23:2015-2020
29. Sedding DG, Hermsen J, Seay U, Eickelberg O, Kummer W, Schwencke C et al. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ Res 2005;96:635-642
30. Gebremedhin D, Terashvili M, Wickramasekera N, Zhang DX, Rau N, Miura H et al. Redox signaling via oxidative inactivation of PTEN modulates pressure-dependent myogenic tone in rat middle cerebral arteries. PLoS One 2013;8:e68498
31. Albinsson S, Nordstrom I, Sward K, Hellstrand P. Differential dependence of stretch and shear stress signaling on caveolin-1 in the vascular wall. Am J Physiol Cell Physiol 2008;294: C271-C279
32. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004;37:449-471
33. Mohamed JS, Lopez MA, Boriek AM. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta. J Biol Chem 2010;285:29336-29347
34. Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A, Essin K et al. Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J 2008;27:3092-3103
35. Gschwend S, Henning RH, Pinto YM, de ZeeuwD, van Gilst WH, Buikema H. Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: Instantaneous counteraction by acute AT1 receptor blockade. Br J Pharmacol 2003;139:1317-1325
36. Dong X, Yu LG, Sun R, Cheng YN, Cao H, Yang KM et al. Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells. J Cell Biochem 2013;114:174-182
37. Takahashi T, Taniguchi T, Konishi H, Kikkawa U, Ishikawa Y, Yokoyama M. Activation of Akt/protein kinase B after stimulation with angiotensin II in vascular smoothmuscle cells. Am J Physiol 1999;276:H1927-H1934
38. Massett MP, Ungvari Z, Csiszar A, Kaley G, Koller A. Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. Am J Physiol Heart Circ Physiol 2002;283:H2282-H2287
39. Nowicki PT, Flavahan S, Hassanain H, Mitra S, Holland S, Goldschmidt-Clermont PJ et al. Redox signaling of the arteriolar myogenic response. Circ Res 2001;89:114-116
40. Ying Z, Giachini FR, Tostes RC,Webb RC. PYK2/PDZ-RhoGEF links Ca2+ signaling to RhoA. Arterioscler Thromb Vasc Biol 2009;29:1657-1663
41. Guilluy C, Bregeon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 2010;16:183-190